CARM – carisma therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

CARM

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

2/19

07:30 am

carm

Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference

Low Report

Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference

Report

2/5

08:02 am

carm

Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference [Yahoo! Finance]

High Report

Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference [Yahoo! Finance]

Report

2/5

07:30 am

carm

Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference

High Report

Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference

Report

1/13

08:11 am

carm

Carisma Therapeutics, Inc. (NASDAQ: CARM) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $12.00 price target on the stock.

Medium Report

Carisma Therapeutics, Inc. (NASDAQ: CARM) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $12.00 price target on the stock.

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.